Related Experiment Video

Updated: Jul 25, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

[Mortality in pediatric anesthesia]

P Rothstein1

  • 1Anestesia Clinica e Pediatrica Clinica, College of Physicians and Surgeons of Columbia University, New York, NY, USA. ptr1@columbia.edu

Minerva Anestesiologica
|June 8, 2004
PubMed

Insights

Infant mortality risk is higher in newborns and infants due to underdeveloped hearts needing more oxygen. Positive pressure ventilation may interfere with neonatal circulation, necessitating further research on anesthetic agents like sevoflurane.

Area of Science:

  • Neonatal physiology and cardiovascular development.
  • Anesthetic implications in pediatric surgery.
  • Causes and prevention of infant mortality.

Context:

  • Infant mortality rates remain a concern, particularly in newborns and infants aged 5-6 months.
  • Neonatal hearts have unique physiological demands, requiring higher oxygen levels compared to older children.
  • The interaction between positive pressure ventilation and neonatal circulation is a potential contributor to mortality.

Purpose:

  • To investigate the causes of mortality in newborns and infants during surgical procedures.
  • To evaluate the safety and efficacy of anesthetic agents, specifically sevoflurane, in this vulnerable population.
  • To identify risk factors associated with anesthetic administration and ventilation strategies.

Summary:

  • Studies indicate a higher risk of mortality in infants aged 5-6 months, likely due to their underdeveloped cardiovascular systems and increased oxygen requirements.
  • Positive pressure ventilation may negatively impact neonatal circulation, contributing to adverse outcomes.
  • While alothane has been implicated in past studies, more research is needed on sevoflurane's effectiveness and safety profile.
  • Complication rates were observed to be higher with certain anesthetic approaches compared to pediatric anesthesia specialists.

Impact:

  • Highlights the need for further randomized controlled studies to elucidate the precise causes of perioperative infant mortality.
  • Informs the development of safer anesthetic protocols and ventilation strategies for neonatal surgery.
  • Aims to reduce infant mortality in the operating room through evidence-based interventions and improved clinical practices.
Abstract

More Related Videos

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Related Concept Videos

Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...